Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report

RATIONALE: Though the majority of differentiated thyroid cancer (DTC) patients have a good prognosis after careful and standardized therapy, approximately 13% to 15% of DTC cases show surprisingly aggressive behavior and invasion of the surrounding structures, and a few progress to unresectable dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yingchao, Deng, Xianzhao, Ding, Zheng, Kang, Jie, Wu, Bo, Guo, Bomin, Fan, Youben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281949/
https://www.ncbi.nlm.nih.gov/pubmed/33761701
http://dx.doi.org/10.1097/MD.0000000000025191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281949/
https://www.ncbi.nlm.nih.gov/pubmed/33761701
http://dx.doi.org/10.1097/MD.0000000000025191

Ejemplares similares